Heart Disease Clinical Trials in Chicago

Showing 141-160 of 440 trials

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

NCT03541603

Phase 2 study to evaluate the efficacy and safety of intermittent levosimendan compared with placebo in hemodynamic improvement with exercise in PH-HFpEF subjects

Hypertension Pulmonary SecondaryHeart Failure, Right SidedHeart Failure With Normal Ejection Fraction

Tenax Therapeutics, Inc.44 participantsStarted Nov 2018

Stanford, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +13 more locations

COMPLETED2.2 miles

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

NCT02178943

Plasma donor-derived cell-free DNA (dd-cfDNA) is measured as a % of the total plasma cfDNA in association with the measurement of AlloMap, a non-invasive gene expression test to aid in heart transplant management.

Cardiac Transplant FailureCardiac Transplant RejectionHeart Diseases

CareDx100 participantsStarted Jun 2014

Beverly Hills, California, United States • Los Angeles, California, United States • Stanford, California, United States +25 more locations

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

Heart Disease Trials in Other Cities

REmodeling the Left Ventricle With Atrial Modulated Pacing

Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention (ARIVE-PCI) Registry

Physiologic Pacing Registry

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

A Feasibility Study on Ultrafiltration and Blood Volume Measurements

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Use of Oxandrolone to Promote Growth in Infants With HLHS

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

Rivet PVS Therapy in Group 2 PH-HFpEF

Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates

Acorai Machine Learning Generalization (MLG) Study

Other Conditions in Chicago